Barry Investment Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$261K Sell
1,036
-24
-2% -$5.16K 0.05% 82
2026
Q1
$231K Hold
1,060
0.05% 85
2025
Q4
$242K Sell
1,060
-79
-7% -$18K 0.05% 85
2025
Q3
$264K Sell
1,139
-210
-16% -$42.8K 0.06% 88
2025
Q2
$250K Sell
1,349
-610
-31% -$113K 0.06% 91
2025
Q1
$411K Buy
1,959
+2
+0.1% +$389 0.11% 76
2024
Q4
$348K Buy
1,957
+2
+0.1% +$368 0.11% 80
2024
Q3
$386K Sell
1,955
-83
-4% -$15.5K 0.12% 78
2024
Q2
$350K Buy
2,038
+3
+0.1% +$497 0.12% 83
2024
Q1
$371K Buy
2,035
+2
+0.1% +$345 0.12% 83
2023
Q4
$315K Sell
2,033
-7
-0.3% -$1.02K 0.11% 85
2023
Q3
$304K Buy
2,040
+2
+0.1% +$294 0.11% 85
2023
Q2
$275K Sell
2,038
-52
-2% -$7.63K 0.09% 99
2023
Q1
$333K Buy
2,090
+2
+0.1% +$306 0.11% 88
2022
Q4
$337K Buy
2,088
+17
+0.8% +$2.61K 0.11% 88
2022
Q3
$278K Sell
2,071
-58
-3% -$8.32K 0.1% 90
2022
Q2
$326K Sell
2,129
-411
-16% -$62.8K 0.1% 94
2022
Q1
$412K Buy
2,540
+118
+5% +$17.1K 0.11% 94
2021
Q4
$328K Buy
+2,422
New +$286K 0.09% 93
2021
Q3
Sell
-1,857
Closed -$209K 120
2021
Q2
$209K Buy
+1,857
New +$209K 0.06% 113

Other funds holding ABBV

Barry Investment Advisors's ABBV Position: Q2 2026 in Review

Barry Investment Advisors reduced its AbbVie (ABBV) stake by 2.3% in Q2 2026, selling an estimated $5.16K and leaving 1,036 shares worth $261K. The position accounts for 0.05% of the portfolio, ranked #82.

Barry Investment Advisors first reported a position in ABBV in Q2 2021 and has held it in 20 quarters since. The position peaked at $412K in Q1 2022. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Barry Investment Advisors held 1,036 shares of AbbVie worth $261K as of Q2 2026.
  • Barry Investment Advisors sold 24 AbbVie shares in Q2 2026, an estimated $5.16K.
  • AbbVie made up 0.05% of Barry Investment Advisors's portfolio in Q2 2026, its #82 holding.
  • Barry Investment Advisors first reported a position in AbbVie in Q2 2021 and has held it in 20 quarters since.
  • Barry Investment Advisors's AbbVie position peaked at $412K in Q1 2022.
  • 4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Barry Investment Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.